Table 4.
CHD(n = 39) | Stroke(n = 122) | CVD(n = 149) | ||||
---|---|---|---|---|---|---|
Crude HR (95 %CI) | Adjusted HR (95 %CI) | Crude HR (95 %CI) | Adjusted HR (95 %CI) | Crude HR (95 %CI) | Adjusted HR (95 %CI) | |
MetS by different criteria (ref = non- MetS) | ||||||
NCEP ATP III | 1.36(0.60,3.08) | 1.29(0.55,2.99) | 1.19(0.74,1.92) | 1.28(0.79,2.09) | 1.16(0.74,1.80) | 1.25(0.80,1.97) |
AHA/NHLBI | 1.21(0.57,2.55) | 1.14(0.53,2.44) | 1.31(0.87,1.99) | 1.41(0.92,2.15) | 1.23(0.84,1.81) | 1.32(0.90,1.96) |
IDF | 1.10(0.51,2.41) | 0.98(0.44,2.18) | 1.43(0.95,2.16) | 1.35(0.88,2.06) | 1.36(0.94,1.98) | 1.28(0.87,1.89) |
Metabolic components (ref = no) | ||||||
Elevated Blood pressure | 0.60(0.27,1.30) | 0.53(0.24,1.19) | 0.99(0.60,1.63) | 0.98(0.59,1.63) | 0.88(0.57,1.36) | 0.86(0.55,1.35) |
Hypertriglycerides | 1.15(0.56,2.38) | 1.24(0.59,2.58) | 1.25(0.84,1.87) | 1.33(0.89,2.00) | 1.13(0.78,1.64) | 1.24(0.85,1.81) |
Low HDL-C | 1.58(0.72,3.44) | 1.19(0.54,2.64) | 0.89(0.52,1.50) | 0.90(0.52,1.53) | 0.99(0.62,1.57) | 0.97(0.61,1.55) |
Abdominal obesity (NCEP ATP III and AHA/NHLBI) a | 2.07(0.50,8.62) | 2.17(0.52,9.14) | 0.56(0.14,2.27) | 0.56(0.14,2.27) | 1.06(0.39,2.85) | 1.10(0.41,2.98) |
Abdominal obesity (IDF) b | 1.21(0.60,2.45) | 1.12(0.54,2.31) | 1.17(0.79,1.74) | 1.08(0.71,1.643 | 1.20(0.84,1.72) | 1.12(0.77, 1.62) |
High FPG (NCEP ATP III) c | 1.70(0.89,3.26) | 1.72(0.88,3.34) | 1.10(0.75,1.63) | 1.15(0.77,170) | 1.22(0.86,1.72) | 1.26(0.89, 1.79) |
High FPG (AHA/NHLBI and IDF) d | 1.15(0.60,2.19) | 1.14(0.59,2.19) | 1.16(0.81,1.67) | 1.18(0.82,1.71) | 1.19(0.86,1.65) | 1.22(0.88,1.71) |
Adjusted for sex, age, marital status, education, physical activity, currently smoking (yes, no), currently drinking (yes, no), family history of CHD, family history of stroke and family history of hypertension. a Waist circumference ≥ 102 cm in men and ≥ 88 cm in women. b Waist circumference ≥ 90 cm in men and ≥ 80 cm in women. c Fasting glucose level of ≥ 6.1 mmol/L. d Fasting glucose level of ≥ 5.6 mmol/L.